SPARC enters into licensing agreement with Biomodifying to acquire exclusive rights for antibody… EP News Bureau Dec 4, 2021 Under the agreement, Biomodifying is eligible for an upfront payment, milestone payments on pre-specified clinical, regulatory,…
